BIOLIFE SOLUTIONS INC
DelistedCIK 834365fmd_0JPM53P1C1WE8Q2QZEW7MY6V20Manufacturing · Electromedical & Electrotherapeutic ApparatusTemplate: Standard
Coverage: Jan 01, 2010 to Jun 30, 2026, 65 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | 11 | 20 | 27 | 48 | 119 | 76 | 68 | 75 | 96 |
| Cost of revenue | 3 | 4 | 6 | 9 | – | – | – | 27 | 25 | 34 |
| Gross profit | 5 | 7 | 14 | 19 | – | – | – | 41 | 50 | 62 |
| Realized investment gains (losses) | – | – | – | 0 | 1 | 0 | 1 | 0 | (4) | 0 |
| Research and development | 2 | 1 | 1 | 3 | 7 | 12 | 9 | 6 | 5 | 8 |
| Selling, general and administrative | 8 | 7 | 9 | 14 | 22 | 48 | 45 | 54 | 50 | 55 |
| Total operating expenses | 10 | 8 | 10 | – | – | – | – | – | – | – |
| Operating income | (5) | (1) | 4 | (0) | (6) | (35) | (6) | (17) | (4) | (17) |
| Interest expense | 0 | 0 | 0 | 0 | – | – | – | – | – | – |
| Interest and investment income | – | – | 0 | 1 | 0 | – | – | – | – | – |
| Other non-operating income (expense) | (3) | (1) | (29) | (3) | 5 | 6 | 1 | 5 | (4) | 5 |
| Income before taxes | – | (3) | (25) | (3) | (1) | (29) | (5) | (12) | (9) | (12) |
| Income tax expense | 0 | 0 | – | (2) | (3) | (20) | (5) | (0) | (0) | 0 |
| Net income from continuing operations | – | (3) | – | (2) | 2 | (9) | 0 | (12) | (9) | (12) |
| Net income | (7) | (3) | (25) | (2) | 2 | (9) | (140) | (68) | (20) | (5) |
| Net income to common shareholders | (7) | (3) | (25) | (2) | 2 | (9) | (140) | (66) | – | – |